Medical Weight Loss And Health Care Of Western New York East Amherst NY 14051 – Video


Medical Weight Loss And Health Care Of Western New York East Amherst NY 14051
http://www.localedge.com/b29915052/Medical+Weight+Loss+And+Health+Care+Of+Western+New+York?type= If you have been fighting your weight for most of your life, you are not alone. Dr. Meng and...

By: LocalEdge VideosSeven

View original post here:

Medical Weight Loss And Health Care Of Western New York East Amherst NY 14051 - Video

Supplements Manufacturing – Italian organic health care products for Distributors – Video


Supplements Manufacturing - Italian organic health care products for Distributors
Organic supplements manufacturing produced in Italy, health dietary and food organic supplements manufacturer for worldwide distributors using Italian organic Lycopene. For more info visit...

By: Italian Business Guide

Read the original:

Supplements Manufacturing - Italian organic health care products for Distributors - Video

Orientation Lectures (2014) – UNAIDS : Standard precautions of health care settings – Video


Orientation Lectures (2014) - UNAIDS : Standard precautions of health care settings
Introduction lecture 22-9-2014 for 1st year students of Kasr al-Ainy faculty of medicine Host : Students union of Kasr al-Ainy By Walid Hassan (2009-2015) , UNAIDS trainer.

By: Abdelaziz el Shabouny

See the article here:

Orientation Lectures (2014) - UNAIDS : Standard precautions of health care settings - Video

Report identifies game changers for U.S. health care

By Karen Pallarito HealthDay Reporter

(HealthDay News) -- Imagine if doctors and hospitals got paid for providing better care, not more care, and consumers had better data for making informed health choices.

A new report suggests that's the direction the U.S. health system is headed.

The report, from the IMS Institute for Healthcare Informatics in Parsippany, N.J., identifies 10 "harbingers of change" -- recent events expected to alter the delivery of health care and use of medicines over the next decade.

The authors concede that poor adoption of new technologies, worries about data privacy and other obstacles could slow the pace of change, but their long-term outlook for patient care is hopeful.

"I think there can be optimism about the effectiveness of the care [patients] receive and even the cost of it," said Murray Aitken, executive director of the institute, as well as one of the study's authors.

One indication of what lies ahead: the entry of such technology juggernauts as Apple, Google and Samsung into the health care marketplace, according to the report.

IMS predicts greater innovation in mobile health applications and wearable health devices that cull personal health data and monitor everything from physical activity to blood-sugar levels.

"These new technologies get people more engaged in their own health care," Aitken said.

And with a consumer's permission, a doctor could tap into that data to tweak medication levels without the patient having to make an appointment.

The rest is here:

Report identifies game changers for U.S. health care

Carl Leubsdorf: Health care battles continue to roil

Last winter, Virginias Republican legislative majority blocked Democratic Gov. Terry McAuliffes plan to extend Medicaid to 400,000 Virginians without medical insurance.

Afterwards, McAuliffe vowed to take executive action but discovered legal restrictions limited him to adding 25,000 people to the rolls, mostly those with mental illnesses, though he included funds to encourage 160,000 more to enroll in private insurance.

As a result, he was denounced for failing to live up to his vow by the same Virginia GOP whose legislators blocked Medicaid expansion in the first place.

To make sure he failed, the Legislatures Republican majority last week again blocked what The Washington Post termed McAuliffes top legislative priority.

Once again, Terry McAuliffe has far over-promised, and mightily under-delivered, said state GOP communications director Garren Shipley, echoing the way Republican officials regularly portray actions limiting the Affordable Care Act as defeats for Democrats like McAuliffe and President Barack Obama.

In truth, preventing Medicaid expansion or other aspects of Obamacare in Virginia and other states, including Texas, is less a defeat for its political champions than a defeat for millions of Americans. After all, their participation in the landmark universal health care program is at stake when states consider the expanded Medicaid program, at mostly federal cost, or courts decide if its legal for them to receive a federal subsidy.

As a result, 375,000 poor and often elderly Virginians will still be denied health insurance. Over the next 10 years, the Urban Institute and the Robert Wood Johnson Foundation estimated, the state will lose $1.5 billion in additional Medicaid funds and its hospitals will lose more than $6 billion in reimbursements.

That pattern has been repeated on an even larger scale in Texas. The Urban Institute-Johnson Foundation analysis estimated more than 1.5 million people would be denied Medicaid coverage because Gov. Rick Perry rejected federal funds to underwrite 90 percent of the cost. The state will lose a potential $65.6 billion in federal funding.

By 2016, the Urban Institute says, those Texas numbers would deny 176,000 cholesterol screens, 44,100 Mammograms, 75,200 Pap smears and 3.2 million additional physicians visits for Medicaid-eligible Texans.

That pattern has been repeated in other states where Republican governors or legislatures have sought to undermine or halt the Affordable Care Act, preventing more than 5 million Americans in 20 states from participating in Medicaid.

Visit link:

Carl Leubsdorf: Health care battles continue to roil

3 health-care stocks look strong: Pro

"So, large-cap biotechs have done well this year," he said. "We went back and actually analyzed what's driven that outperformance. Interestingly, the majority of the outperformance has been driven by new-product introductions and earnings upside because of leverage down to P&L.

"The multiple has actually contracted, which I think is kind of counterintuitive to what the public believes."

Read More3 top biotech stocks with big upside: Pro

Over the next year or two, the large-cap biotech sector is likely to see "robust data flow, new clinical data announcements, continued momentum in terms of the blockbuster product launches and the P&L leverage to drive earnings," Chai added.

"And in a way, we can envision a scenario where now sentiment, which we define as sort of the multiple, can catch up to fundamentals."

Chai said that his top three health-care stock picks are: Medtronic, which should do well regardless of how its proposed tax-inversion deal with Covidien turns out; pharmaceutical company Sanofi, and Tornier, a medical-device manufacturer that should benefit from a variety of factors, including recent restructuring and potential consolidation.

Read this article:

3 health-care stocks look strong: Pro

Quebecs Couillard Plans Health-Care Cuts to Trim Deficit

Quebec expects to save C$220 million ($199 million) by eliminating hundreds of administrative jobs in health care to help balance the budget next year, Premier Philippe Couillard said.

We have a very complex health-care system, Couillard, 57, said yesterday in an interview at Bloomberg headquarters in New York. Theres a vast reform thats going to be announced this week of doing away with most of the bureaucracy in the system, freeing money to be dedicated to the patients.

Couillard, a neurosurgeon and former health minister, was elected in April as leader of Canadas second most-populous province after promising to shrink the bureaucracy. He has vowed to plug a C$2.35 billion budget gap in 2015-16 with the help of measures such as spending cuts and a hiring freeze.

Health care is Quebecs largest expenditure, accounting for about C$37.3 billion, or 43 percent, of the governments program spending of C$86.6 billion this fiscal year.

Quebecs health-care spending climbed by an average of 5.6 percent a year in the decade ended in March, budget figures show. With demographic projections showing that the provinces working-age population will start declining in 2017, investors such as Hosen Marjaee of Manulife Asset Management warn that costs could climb even faster.

Since his election, Couillard created two committees to overhaul government programs and the provinces taxation system. He gave the program review committee a mandate to find more than C$3 billion in savings.

Quebec has long-term demographic issues, Marjaee, who manages about C$19 billion and owns Quebec bonds, said in a telephone interview from Toronto. So far, it appears that the government of Mr. Couillard will take the necessary steps to curb the deficit.

The health-care reform will likely entail the elimination of regional bodies that oversee hospitals, the premier said.

Were removing a layer of administration, Couillard said. We have a ministerial layer, a regional layer and a local layer. Were essentially going to do away with the regional layer.

Cutting costs is difficult, Douglas Offerman, a senior director at Fitch Ratings in New York, said in a telephone interview. There are services that people depend on, and its always challenging. Its the turn of the expense side of the budget to provide some savings now.

Read the original:

Quebecs Couillard Plans Health-Care Cuts to Trim Deficit

These 3 hot health-care stocks look strong: Pro

"So, large-cap biotechs have done well this year," he said. "We went back and actually analyzed what's driven that outperformance. Interestingly, the majority of the outperformance has been driven by new-product introductions and earnings upside because of leverage down to P&L.

"The multiple has actually contracted, which I think is kind of counterintuitive to what the public believes."

Read More3 top biotech stocks with big upside: Pro

Over the next year or two, the large-cap biotech sector is likely to see "robust data flow, new clinical data announcements, continued momentum in terms of the blockbuster product launches and the P&L leverage to drive earnings," Chai added.

"And in a way, we can envision a scenario where now sentiment, which we define as sort of the multiple, can catch up to fundamentals."

Chai said that his top three health-care stock picks are: Medtronic, which should do well regardless of how its proposed tax-inversion deal with Covidien turns out; pharmaceutical company Sanofi, and Tornier, a medical-device manufacturer that should benefit from a variety of factors, including recent restructuring and potential consolidation.

Originally posted here:

These 3 hot health-care stocks look strong: Pro

TOO HOT? Feverish Health Care Investment By REITs Poses Risks for Investors

Analysts Worry 'Frothy' Market for Health Care Real Estate May Erode Yields, Leave Some Buyers With Bad Case of Debt

Some analysts, however, are concerned that certain investors may end up in traction. While the most recent acquisitions highlight the segment's continued rapid growth, Fitch Ratings recently issued a report raising questions about the risk that a growing pool of buyers from all end of the investment spectrum may end up overpaying for properties, pursue higher-yield, higher-risk assets, or go into debt to maintain the frenzied growth pace that investors have come to expect from the sector.

To date, publicly traded health care REITs, the largest suppliers of investment capital, have funded their growth conservatively and without significant leverage, benefiting from opportunistic equity raises at substantial premiums to net asset value (NAV), Fitch said. But the rating agency warned that growth expectations for this sector may be difficult to maintain.

"We believe the premiums reflect shareholders' expectations of continued growth, and continuing to satisfy these expectations may prove challenging," according to research headed by Fitch Director Britton O. Costa.

While publicly traded REITs remain the largest suppliers of health-care property capital, private buyers such as non-traded REITs are also jumping into the game, aggressively buying properties and keeping capitalization rates low and prices high, said PJ Camp, principal with Hammond Hanlon Camp LLC, a health care-focused independent investment banking and advisory firm.

"Clearly there are more players in the market than ever before. It's hard to find anyone who doesn't want to be in the space," Camp said during a presentation on MOB mergers and acquisition activity this week by Levin & Associates.

Medical office buildings, assisted-living facilities and other health care real estate were ranked as the most attractive property investment this year and over the next 12 months, for the first time surpassing multifamily and industrial assets, according to DLA Piper's 2014 State of the Market Survey released earlier this month.

However, despite their favored status, health-care properties are still not producing yields as high as some other asset classes, DLA Piper noted. The firm cited research from Green Street Advisors that the average cap rate on health care properties was about 6.8% in July -- down from about 7.2% a year earlier but still nearly two percentage points higher than average yields on office or apartment buildings.

Meanwhile, investors continue to raise cash and pour money into the health-care space, with the REIT sector being particularly active, including property acquisitions, M&A deals and initial public offerings.

Health Care REIT, Inc. (NYSE:HCN) announced recently that it anticipates acquiring about $1.7 billion of properties in the second half of 2014, including the previously announced deals to acquire HealthLease Properties REIT for $950 million, the $257 million transaction with Sunrise Senior Living to buy Gracewell Healthcare. HCN expects to invest $535 million in new deals expected to consummate before the end of the year.

Read the original here:

TOO HOT? Feverish Health Care Investment By REITs Poses Risks for Investors